Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains
Authors:
- Toby E. StuartTSToby E. Stuart
- Salih Zeki OzdemirSOSalih Zeki Ozdemir
- Waverly W. DingWDWaverly W. Ding
- 1 May 2007
- journal article
- Published by Elsevier in Research Policy
- Vol. 36 (4) , 477-498
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Structural Holes and Good IdeasAmerican Journal of Sociology, 2004
- Value creation and sharing among universities, biotechnology and pharmaNature Biotechnology, 2003
- Why do some universities generate more start-ups than others?Research Policy, 2003
- The effects of business–university alliances on innovative output and financial performance: a study of publicly traded biotechnology companiesJournal of Business Venturing, 2002
- When Does Start-Up Innovation Spur the Gale of Creative Destruction?The RAND Journal of Economics, 2002
- Collaboration Networks, Structural Holes, and Innovation: A Longitudinal StudyAdministrative Science Quarterly, 2000
- Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug DiscoveryThe Journal of Industrial Economics, 1998
- Complementarity and External Linkages: The Strategies of the Large Firms in BiotechnologyThe Journal of Industrial Economics, 1990
- Power and Centrality: A Family of MeasuresAmerican Journal of Sociology, 1987
- Positions in NetworksSocial Forces, 1976